Your browser doesn't support javascript.
loading
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract.
Alhalabi, Omar; Wilson, Nathaniel; Xiao, Lianchun; Lin, Yiyun; Khandelwal, Jaanki; Moussa, Mohammad Jad; Msaouel, Pavlos; Navai, Neema; Gao, Jianjun; Kamat, Ashish M; Pilie, Patrick; Shah, Amishi Y; Goswami, Sangeeta; Matin, Surena; Kovitz, Craig; Holla, Vijaykumar; Guo, Charles; Czerniak, Bogdan; Logothetis, Christopher; Corn, Paul G; Dinney, Colin P N; Campbell, Matthew T; Hansel, Donna E; Tannir, Nizar M; Siefker-Radtke, Arlene O.
Afiliación
  • Alhalabi O; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: oalhalabi@mdanderson.org.
  • Wilson N; Department of Internal Medicine, University of Texas Houston, McGovern Medical School, Houston, TX, USA.
  • Xiao L; Department of Statistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lin Y; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Khandelwal J; Department of Internal Medicine, University of Texas Houston, McGovern Medical School, Houston, TX, USA.
  • Moussa MJ; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Msaouel P; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; David H. Koch Center for Applied Research
  • Navai N; Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gao J; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kamat AM; Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pilie P; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shah AY; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Goswami S; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Matin S; Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kovitz C; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Holla V; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Guo C; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Czerniak B; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Logothetis C; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Corn PG; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dinney CPN; Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Campbell MT; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hansel DE; Division of Pathology-Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tannir NM; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Siefker-Radtke AO; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: asiefker@mdanderson.org.
Eur Urol Oncol ; 6(6): 611-620, 2023 12.
Article en En | MEDLINE | ID: mdl-37833193
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema Urinario / Neoplasias de la Vejiga Urinaria / Carcinoma Neuroendocrino Límite: Humans Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema Urinario / Neoplasias de la Vejiga Urinaria / Carcinoma Neuroendocrino Límite: Humans Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article